Like many of its peers, Tilray is struggling after its fiscal 2019 third-quarter release. Though its revenue met estimates, its stock continues to slide.
GW Pharmaceuticals (GWPH) recently reported its QA3 results. Although its financials beat estimates, the company's stock has fallen 18% since then.
Curaleaf is set to report its third-quarter earnings results on November 19. It's fallen more than 6% since it announced its earnings date.
As of October 30, Charlotte's Web Holdings (CWEB) had lost 6.39% of its value in the month and was trading at 17.33 Canadian dollars.
So far, cannabis stocks have struggled this year. Many of the stocks didn’t impress investors with their earnings results. Analysts downgraded and cut many...
New Jersey legalized cannabis for medical use for certain conditions in 2010. However, its efforts to legalize recreational use have been unsuccessful.